CompuMed, Inc.
CMPD · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $4,779 | $4,939 | $6,704 | $13,837 |
| - Cash | $1,564 | $1,079 | $1,799 | $2,213 |
| + Debt | $523 | $393 | $538 | $765 |
| Enterprise Value | $3,738 | $4,253 | $5,443 | $12,390 |
| Revenue | $6,222 | $5,838 | $6,365 | $6,317 |
| % Growth | 6.6% | -8.3% | 0.8% | – |
| Gross Profit | $3,025 | $2,886 | $3,304 | $3,345 |
| % Margin | 48.6% | 49.4% | 51.9% | 53% |
| EBITDA | $952 | $690 | $1,119 | $1,481 |
| % Margin | 15.3% | 11.8% | 17.6% | 23.4% |
| Net Income | $193 | -$33 | $502 | $1,067 |
| % Margin | 3.1% | -0.6% | 7.9% | 16.9% |
| EPS Diluted | 0.15 | -0.021 | 0.3 | 0.69 |
| % Growth | 817.7% | -107% | -56.5% | – |
| Operating Cash Flow | $877 | $520 | $736 | $1,419 |
| Capital Expenditures | -$522 | -$370 | -$909 | -$882 |
| Free Cash Flow | $355 | $150 | -$173 | $537 |